Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development Sanofi appoints Muzammil Mansuri as Executive Vice President, Strategy & Business Development Also joins the Executive Committee at the French drugmaker New VP of Development and Analytical Services at Catalent New VP of Development and Analytical Services at Catalent New VP of Development and Analytical Services at Catalent Sally Langa joins the US drug delivery technology specialist David Budd to join Epistem as Chief Executive David Budd to join Epistem as Chief Executive He will start his new role by the middle of April CytRx appoints Olivia Ware as Chief Commercial Officer CytRx appoints Olivia Ware as Chief Commercial Officer Los Angeles-based firm specialises in oncology and is preparing for the results of a pivotal Phase III trial Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals He previously held managerial and business development roles at Teva Pharmaceuticals and Dexcel Pharma Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs He joins the firm with more than 15 years of vaccine research and development experience and leadership roles AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business Dawn Von Rohr joins AMRI from Mallinckrodt Pharmaceuticals where she was VP and General Manager, Global APIs Paolo Paoletti joins PsiOxus Therapeutics at Chairman Paolo Paoletti joins PsiOxus Therapeutics at Chairman Former President of GSK Oncology adds depth of knowledge of cancer R&D Merck announces new biopharma heads for North America and China Merck announces new biopharma heads for North America and China Merck announces new biopharma heads for North America and China Gary Zieziula and Marc Horn to head biopharma business in North America and China, respectively Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis Will build sales in the Boston Biotech community Avacta hires Philippe Cotrel as Chief Commercial Officer Avacta hires Philippe Cotrel as Chief Commercial Officer Joins the UK firm from Abcam Averica Discovery appoints Cynthia Berger as Vice President of Operations Averica Discovery appoints Cynthia Berger as Vice President of Operations Averica Discovery appoints Cynthia Berger as Vice President of Operations Will contribute broadly to the firm's growth and development Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult The new Medicines Technologies Catapult at Alderley Park, Cheshire, UK, will support industry in developing new technologies primarily for the preclinical evaluation of medicines Recipharm appoints new Key Account Director for Europe Recipharm appoints new Key Account Director for Europe Recipharm appoints new Key Account Director for Europe Anke Mollowitz is responsible for coordinating customer management and commercial aspects Remi Palmantier becomes Chief Scientific Officer at Genticel Remi Palmantier becomes Chief Scientific Officer at Genticel Will accelerate the discovery, development and integration of specific immunotherapies Chief Medical Officer Birgitte Volck to leave Sobi Chief Medical Officer Birgitte Volck to leave Sobi To join GlaxoSmithKline as Head of R&D Rare Diseases
  • Previous
  • 1
  • …
  • 100
  • 101
  • 102
  • 103 (current)
  • 104
  • 105
  • 106
  • …
  • 213
  • Next

Trending Articles

  1. MasterControl strengthens executive leadership team with two key appointments Wynn Clayton joins as CFO while Ian Ball is promoted to chief sales officer to support the company’s next phase of growth
  2. MHRA scientific leader recognised in 2026 King's Birthday Honours Dr Nicola Rose receives OBE for services to science and public health
  3. Servomex appoints new Global Sales Director Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
  4. Hansa Biopharma appoints Fredrik Röök as VP Business Development Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
  5. Ardena appoints Ariane de Ganck as Chief Scientific Officer Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.